{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:30:39Z","timestamp":1740807039083,"version":"3.38.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brachy.2024.11.010","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T12:23:57Z","timestamp":1736252637000},"page":"248-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The influence of time and implants in high-dose rate image-guided adaptive brachytherapy for locally advanced cervical cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9138-7604","authenticated-orcid":false,"given":"Leonel Varela","family":"Cagetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Gonzague-Casabianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-5681","authenticated-orcid":false,"given":"Marjorie","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Gilhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-3953","authenticated-orcid":false,"given":"Eric","family":"Lambaudie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Blache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Jauffret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magalie","family":"Provansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-682X","authenticated-orcid":false,"given":"Renaud","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Tallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","key":"10.1016\/j.brachy.2024.11.010_bib0001"},{"key":"10.1016\/j.brachy.2024.11.010_bib0002","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2024.11.010_bib0003","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage llB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.brachy.2024.11.010_bib0004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2024.11.010_bib0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","article-title":"Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer","volume":"100","author":"P\u00f6tter","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0006","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.brachy.2024.11.010_bib0007","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijrobp.2010.10.030","article-title":"International brachytherapy practice patterns: A survey of the Gynecologic Cancer Intergroup","volume":"82","author":"Viswanathan","year":"2012","journal-title":"Int J Radiat Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy\u2014An American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0011","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2005.02.015","article-title":"Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions","volume":"97","author":"Souhamia","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0012","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ijgc-2018-000057","article-title":"Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer","volume":"29","author":"Horeweg","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2024.11.010_bib0013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brachy.2022.11.005","article-title":"Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy","volume":"22","author":"Scott","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0014","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ijrobp.2021.06.014","article-title":"Single application multifractionated image guided adaptive high-dose-rate brachytherapy for cervical cancer: dosimetric and clinical outcomes","volume":"111","author":"Mahantshetty","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2023.11.014","article-title":"Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US","volume":"180","author":"Hsieh","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.canrad.2021.03.006","article-title":"Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience","volume":"25","author":"Ogorodniitchouk","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2024.11.010_bib0017","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2017.09.009","article-title":"Radiobiological analysis of outcomes using external beam radiotherapy plus high dose rate brachytherapy (4 x 7 Gy or 2x9 Gy) for cervical cancer in a multi-institution trial","volume":"99","author":"Hendry","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0018","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2012.05.033","article-title":"Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: Long-term results","volume":"85","author":"Pinn-Bingham","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 2","key":"10.1016\/j.brachy.2024.11.010_bib0019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2024.11.010_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.09.011","article-title":"Integrated PET\/CT for the evaluation of paraaortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings","volume":"108","author":"Yildirim","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0021","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0360-3016(95)00162-R","article-title":"Biologically effective dose distribution based on the linear quadratic model and its clinical relevance","volume":"33","author":"Lee","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0022","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(99)00330-2","article-title":"A simple method of obtaining equivalent doses for use in HDR brachytherapy","volume":"46","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0023","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2020.11.032","article-title":"A phase III randomised trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer","volume":"160","author":"Pareek","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0024","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.brachy.2024.11.010_bib0026","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1278-3218(00)88900-3","article-title":"Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: Report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations","volume":"4","author":"P\u00f6tter","year":"2000","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2024.11.010_bib0027","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.04.012","article-title":"Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer","volume":"83","author":"P\u00f6tter","year":"2007","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.brachy.2024.11.010_bib0028","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.brachy.2021.03.008","article-title":"Reducing dose to rectum by placement of a rectum-emptying tube in cervical cancer patients treated with brachytherapy","volume":"20","author":"Ferr\u00e9","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brachy.2014.11.014","article-title":"Intrafractional organs movement in three-dimensional image-guided adaptive pulsed-dose-rate cervical cancer brachytherapy: Assessment and dosimetric impact","volume":"14","author":"Mazeron","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0030","unstructured":"NCI, CTCAE, available from: https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_5.0\/."},{"key":"10.1016\/j.brachy.2024.11.010_bib0031","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00330-018-5510-3","article-title":"Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: A multicentre study","volume":"29","author":"Thomeer","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.brachy.2024.11.010_bib0032","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.radonc.2016.04.016","article-title":"Long-term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients","volume":"120","author":"Ribeiro","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0033","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3109\/0284186X.2013.818253","article-title":"MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective","volume":"52","author":"Lindegaard","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","article-title":"Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy","volume":"135","author":"Rijkmans","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0035","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3109\/0284186X.2015.1062542","article-title":"Clinical efficacy and toxicity of radiochemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience","volume":"54","author":"Lakosi","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0036","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0037","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2013.01.010","article-title":"Clinical feasibility of combined intracavitary\/ interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem\/ring applicator in situ and virtual preplanning of the interstitial component","volume":"107","author":"Fokdal","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0038","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2019.08.004","article-title":"Vienna-II ring applicator for distal parametrial\/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: clinical feasibility and outcome","volume":"141","author":"Mahantshetty","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0039","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brachy.2016.10.007","article-title":"American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries","volume":"16","author":"Suneja","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0041","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0360-3016(91)90316-V","article-title":"Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation","volume":"21","author":"Orton","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0042","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1278-3218(00)88900-3","article-title":"Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: Report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations","volume":"4","author":"P\u00f6tter","year":"2000","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2024.11.010_bib0043","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0044","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.radonc.2016.05.020","article-title":"Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer","volume":"120","author":"Mohamed","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5114\/jcb.2022.118831","article-title":"Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: Making adverse situations in a favorable scenario","volume":"14","author":"Cagetti","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.010_bib0046","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ctro.2021.10.005","article-title":"High-dose-rate brachytherapy boost for locally advanced cervical cancer: oncological outcome and toxicity analysis of 4 fractionation schemes","volume":"32","author":"Le Guyader","year":"2022","journal-title":"Clin Translat Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0047","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0360-3016(00)00810-5","article-title":"High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells","volume":"49","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.010_bib0048","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0167-8140(95)01695-3","article-title":"Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy","volume":"38","author":"Pop","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0049","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol"},{"issue":"suppl_2","key":"10.1016\/j.brachy.2024.11.010_bib0050","doi-asserted-by":"crossref","first-page":"S1276","DOI":"10.1016\/j.annonc.2023.10.028","article-title":"A randomized phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer. The GCIG INTERLACE trial","volume":"34","author":"McCormack","year":"2023","journal-title":"Annal Oncol"},{"key":"10.1016\/j.brachy.2024.11.010_bib0051","first-page":"1","article-title":"Are we making progress in curing advanced cervical cancer\u2014Again?","volume":"0","author":"Lindegaard","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"10434","key":"10.1016\/j.brachy.2024.11.010_bib0052","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): A randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212400463X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212400463X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:38:28Z","timestamp":1740746308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153847212400463X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S153847212400463X"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.11.010","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of time and implants in high-dose rate image-guided adaptive brachytherapy for locally advanced cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}